Cargando…

Potential new targets for drug development in severe asthma

In recent years there has been increasing recognition of varying asthma phenotypes that impact treatment response. This has led to the development of biological therapies targeting specific immune cells and cytokines in the inflammatory cascade. Currently, there are two primary asthma phenotypes, Ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Linda, Ciaccio, Christina E., Casale, Thomas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203275/
https://www.ncbi.nlm.nih.gov/pubmed/30386455
http://dx.doi.org/10.1186/s40413-018-0208-1